Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
HB4953 • 2026
DRUG DISTRIBUTION RESTRICTIONS
This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.
Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.
DRUG DISTRIBUTION RESTRICTIONS
These notes stay tied to the official amendment files and metadata from the legislature.
Plain English: Illinois General Assembly - Full Text of HB4953 Select Language × The Illinois General Assembly offers the Google Translate™ service for visitor convenience.
Sent to the Governor
Added as Alternate Co-Sponsor Sen. Cristina Castro
Third Reading - Passed; 059-000-000
Passed Both Houses
Added as Alternate Co-Sponsor Sen. Kimberly A. Lightford
Rule 2-10 Third Reading Deadline Established As May 31, 2026
Second Reading
Placed on Calendar Order of 3rd Reading May 25, 2026
Do Pass Licensed Activities ; 006-000-000
Placed on Calendar Order of 2nd Reading May 21, 2026
Rule 2-10 Committee Deadline Established As May 22, 2026
Rule 2-10 Committee Deadline Established As May 15, 2026
Assigned to Licensed Activities
Arrive in Senate
Placed on Calendar Order of First Reading
Chief Senate Sponsor Sen. Laura Ellman
First Reading
Referred to Assignments
Third Reading - Short Debate - Passed 109-000-000
House Floor Amendment No. 2 Adopted
Second Reading - Short Debate
Placed on Calendar Order of 3rd Reading - Short Debate
House Floor Amendment No. 2 Recommends Be Adopted Health Care Licenses Committee ; 014-000-000
House Floor Amendment No. 2 Rules Refers to Health Care Licenses Committee
House Floor Amendment No. 2 Filed with Clerk by Rep. Martha Deuter
House Floor Amendment No. 2 Referred to Rules Committee
Do Pass / Short Debate Health Care Licenses Committee ; 013-000-000
House Committee Amendment No. 1 Tabled
Added Co-Sponsor Rep. Natalie A. Manley
Added Co-Sponsor Rep. Rick Ryan
Placed on Calendar 2nd Reading - Short Debate
House Committee Amendment No. 1 Filed with Clerk by Rep. Martha Deuter
House Committee Amendment No. 1 Referred to Rules Committee
Assigned to Health Care Licenses Committee
First Reading
Referred to Rules Committee
Filed with the Clerk by Rep. Martha Deuter
DRUG DISTRIBUTION RESTRICTIONS
Illinois General Assembly - Full Text of HB4953 Select Language × The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein. Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet. The English language version is always the official and authoritative version of this website. NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window. Choose Language English Afrikaans Albanian Arabic Armenian Azerbaijani Basque Bengali Bosnian Catalan Croatian Czech Danish Dutch Esperanto Estonian Filipino Finnish French Galician Georgian German Greek Gujarati Haitian Creole Hausa Hawaiian Hebrew Hindi Hungarian Icelandic Indonesian Interlingua Interlingue Inuktitut Irish Italian Japanese Javanese Kannada Khmer Korean Latin Latvian Lithuanian Luxembourgish Macedonian Malagasy Malayalam Maltese Maori Marathi Myanmar Nepali Norwegian Odia Pashto Punjabi Romanian Russian Samoan Sango Sanskrit Sardinian Sindhi Sinhala Slovak Slovenian Somali Southern Sotho Spanish Sundanese Swahili Swedish Tamil Telugu Thai Tigrinya Tonga Turkish Ukrainian Urdu Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Powered by Translate Close Illinois General Assembly Top Navigation Bar Translate Learn Select General Assembly Search the 104th General Assembly Enter search terms for legislation, members, committees, or schedules. ILGA.GOV LEGISLATION & LAWS Bills & Resolutions Public Acts Illinois Compiled Statutes Illinois Constitution Search Legislation Glossary Guide Reports & Inquiry Legislative Reports Special Reports FTP Site Legislator Lookup Capitol Complex Phone Numbers Rules & Regulations Illinois Register Administrative Rules Senate Members Schedules Committees Request for Remote Testimony Journals Transcripts Rules Audio/Video FOIA Information Senate Employment Opportunities Media Guidelines House Members Schedules Committees Submit testimony for House Committees Journals Transcripts Rules Audio/Video FOIA Information House Employment Opportunities Log In Mobile Top Bar Search the 104th General Assembly Enter keywords to search the Illinois General Assembly website. Full Text of HB4953 Home Legislation Full Text HB4953 - 104th General Assembly Bill Status Full Text Votes Witness Slips Select Menu Bill Status Full Text Votes Witness Slips Printer Friendly Version Introduced Engrossed Enrolled House Amendment 001 House Amendment 002 Printer Friendly Version Introduced Engrossed Enrolled House Amendment 001 House Amendment 002 Open PDF HB4953 Enrolled LRB104 19403 AAS 32851 b 1 AN ACT concerning regulation. 2 Be it enacted by the People of the State of Illinois, 3 represented in the General Assembly: 4 Section 5. The Wholesale Drug Distribution Licensing Act 5 is amended by changing Section 56 as follows: 6 (225 ILCS 120/56) 7 (Section scheduled to be repealed on January 1, 2028) 8 Sec. 56. Restrictions on transactions. 9 (a) A licensee shall receive prescription drug returns or 10 exchanges from a pharmacy or other persons authorized to 11 administer or dispense drugs or a chain pharmacy warehouse 12 pursuant to the terms and conditions of the agreement between 13 the wholesale distributor and the pharmacy or chain pharmacy 14 warehouse. Returns of expired, damaged, recalled, or otherwise 15 non-saleable pharmaceutical products shall be distributed by 16 the receiving wholesale distributor only to either the 17 original manufacturer or a third party returns processor. 18 Returns or exchanges of prescription drugs, saleable or 19 otherwise, including any redistribution by a receiving 20 wholesaler, shall not be subject to the pedigree requirements 21 of Section 57 of this Act, so long as they are exempt from the 22 pedigree requirement of the FDA's currently applicable 23 Prescription Drug Marketing Act guidance. Both licensees under HB4953 Enrolled - 2 - LRB104 19403 AAS 32851 b 1 this Act and pharmacies or other persons authorized to 2 administer or dispense drugs shall be accountable for 3 administering their returns process and ensuring that the 4 aspects of this operation are secure and do not permit the 5 entry of adulterated and counterfeit product. 6 (b) A manufacturer or wholesale distributor licensed under 7 this Act may furnish prescription drugs only to a person 8 licensed by the appropriate state licensing authorities. 9 Before furnishing prescription drugs to a person not known to 10 the manufacturer or wholesale distributor, the manufacturer or 11 wholesale distributor must affirmatively verify that the 12 person is legally authorized to receive the prescription drugs 13 by contacting the appropriate state licensing authorities. 14 (c) Prescription drugs furnished by a manufacturer or 15 wholesale distributor licensed under this Act may be delivered 16 only to the business address of a licensee, to the premises 17 listed on a the license, or, if the Department has received 18 notice that a licensee has authorized a health care entity to 19 receive the prescription drugs, to the address of a health 20 care entity, provided that the manufacturer or wholesale 21 distributor may furnish prescription drugs to an authorized 22 person or agent of that person at the premises of the 23 manufacturer or wholesale distributor if: 24 (1) the identity and authorization of the recipient is 25 properly established; and 26 (2) this method of receipt is employed only to meet HB4953 Enrolled - 3 - LRB104 19403 AAS 32851 b 1 the immediate needs of a particular patient of the 2 authorized person. 3 Prescription drugs that are controlled substances 4 furnished by a manufacturer or wholesale distributor licensed 5 under this Act may be delivered only to a registered place of 6 business or professional practice, as required by Section 302 7 of the Illinois Controlled Substances Act. 8 For the purposes of this subsection (c), "health care 9 entity" means an entity where medical, dental, or veterinary 10 services are provided by a licensed practitioner and where the 11 licensed practitioner is responsible for the receipt, storage, 12 and use of drugs. 13 (d) Prescription drugs may be furnished to a hospital 14 pharmacy receiving area, provided that a pharmacist or 15 authorized receiving personnel signs, at the time of delivery, 16 a receipt showing the type and quantity of the prescription 17 drug received. Any discrepancy between the receipt and the 18 type and quantity of the prescription drug actually received 19 shall be reported to the delivering manufacturer or wholesale 20 distributor by the next business day after the delivery to the 21 pharmacy receiving area. 22 (e) A manufacturer or wholesale distributor licensed under 23 this Act may not accept payment for, or allow the use of, a 24 person or entity's credit to establish an account for the 25 purchase of prescription drugs from any person other than the 26 owner of record, the chief executive officer, or the chief HB4953 Enrolled - 4 - LRB104 19403 AAS 32851 b 1 financial officer listed on the license of a person or entity 2 legally authorized to receive the prescription drugs. Any 3 account established for the purchase of prescription drugs 4 must bear the name of the licensee. This subsection (e) shall 5 not be construed to prohibit a pharmacy or chain pharmacy 6 warehouse from receiving prescription drugs if payment for the 7 prescription drugs is processed through the pharmacy's or 8 chain pharmacy warehouse's contractual drug manufacturer or 9 wholesale distributor. 10 (Source: P.A. 95-689, eff. 10-29-07 .) Footer Disclaimer This site is maintained for the Illinois General Assembly by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706. Contact ILGA Webmaster ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies. Read About Cookies ILGA.GOV 2026 ILGA.gov | All Rights Reserved | ADA | Disclaimers | Learn This site is maintained for the Illinois General Assembly by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706. Contact ILGA Webmaster ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies. Read About Cookies ILGA.GOV 2026 ILGA.gov | All Rights Reserved | ADA | Disclaimers | Learn